Artivion, Inc. (AORT) Stock Forecast
Data as of Aug 1, 2026Healthcare · Current price $26.71 (-3.36%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 5, 2026 | John McAulay | Stifel Nicolaus | $55.00 | +105.9% |
| Dec 17, 2025 | William Plovanic | Canaccord Genuity | $51.00 | +90.9% |
| Nov 7, 2025 | Suraj Kalia | Oppenheimer | $50.00 | +87.2% |
| Aug 8, 2025 | Mike Matson | Needham | $45.00 | +68.4% |
| Oct 23, 2024 | Daniel Stauder | JMP Securities | $33.00 | +23.5% |
| Aug 9, 2024 | Suraj Kalia | Oppenheimer | $30.00 | +12.3% |
| Jul 10, 2024 | Frank Takkinen | Lake Street | $30.00 | +12.3% |
| Jul 2, 2024 | Frank Takkinen | Loop Capital Markets | $30.00 | +12.3% |
| May 7, 2024 | Mike Matson | Needham | $30.00 | +12.3% |
Top Analysts Covering AORT
AORT vs Sector & Market
| Metric | AORT | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.25 | 2.42 |
| Analyst Count | 8 | 8 | 19 |
| Target Upside | +58.6% | +16366.1% | +18.0% |
| P/E Ratio | 112.72 | 2.91 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $122M | $124M | $126M | 2 |
| 2026-12-31 | $494M | $494M | $495M | 5 |
| 2027-03-31 | $127M | $129M | $131M | 3 |
| 2027-06-30 | $137M | $139M | $140M | 2 |
| 2027-09-30 | $136M | $139M | $140M | 2 |
| 2027-12-31 | $142M | $144M | $146M | 3 |
| 2028-03-31 | $142M | $144M | $146M | 2 |
| 2028-06-30 | $156M | $159M | $160M | 1 |
| 2028-09-30 | $157M | $160M | $161M | 1 |
| 2028-12-31 | $165M | $167M | $169M | 2 |
| 2029-12-31 | $690M | $698M | $702M | 2 |
| 2030-12-31 | $778M | $787M | $792M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $0.10 | $0.10 | $0.11 | 1 |
| 2026-12-31 | $0.35 | $0.36 | $0.36 | 4 |
| 2027-03-31 | $0.15 | $0.15 | $0.16 | 1 |
| 2027-06-30 | $0.17 | $0.17 | $0.17 | 1 |
| 2027-09-30 | $0.19 | $0.20 | $0.20 | 1 |
| 2027-12-31 | $0.24 | $0.24 | $0.24 | 1 |
| 2028-03-31 | $0.15 | $0.15 | $0.15 | 1 |
| 2028-06-30 | $0.19 | $0.19 | $0.19 | 1 |
| 2028-09-30 | $0.20 | $0.20 | $0.20 | 1 |
| 2028-12-31 | $0.24 | $0.24 | $0.24 | 1 |
| 2029-12-31 | $1.31 | $1.33 | $1.34 | 1 |
| 2030-12-31 | $1.69 | $1.72 | $1.73 | 1 |
Frequently Asked Questions
What is the analyst consensus for AORT?
The consensus among 8 analysts covering Artivion, Inc. (AORT) is Buy with an average price target of $40.50.
What is the highest price target for AORT?
The highest price target for AORT is $55.00, set by John McAulay at Stifel Nicolaus on 2026-03-05.
What is the lowest price target for AORT?
The lowest price target for AORT is $30.00, set by Mike Matson at Needham on 2024-05-07.
How many analysts cover AORT?
8 analysts have issued ratings for Artivion, Inc. in the past 12 months.
Is AORT a buy or sell right now?
Based on 8 analyst ratings, AORT has a consensus rating of Buy (2.00/5) with a +58.6% upside to the consensus target of $40.50.
What are the earnings estimates for AORT?
Analysts estimate AORT will report EPS of $0.10 for the period ending 2026-09-30, with revenue estimated at $124M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.